Legal & General Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2
Closed -$5K 3502
2022
Q2
$5K Sell
2
-1
-33% -$2.5K ﹤0.01% 3449
2022
Q1
$9K Hold
3
﹤0.01% 3436
2021
Q4
$17K Hold
3
﹤0.01% 3336
2021
Q3
$25K Buy
3
+1
+50% +$8.33K ﹤0.01% 3202
2021
Q2
$21K Buy
+2
New +$21K ﹤0.01% 3284